All In Biotech

Free tool

FAERS Monitor: Exelon

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022083 or its brand name (Exelon, Rivastigmine). Reports on generic versions are filed under their own applications.

Reports

18,807

Serious

16,024

85% of reports

Hospitalization

6,861

Death reported

4,787

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death2,337
  • fall1,791
  • hallucination1,475
  • confusional state1,331
  • drug ineffective957
  • vomiting909
  • nausea858
  • dizziness811
  • gait disturbance751
  • pneumonia728
  • somnolence692
  • fatigue681
  • malaise673
  • diarrhoea659
  • condition aggravated653

Reports by year received

View as table
YearReports
2004323
2005236
2006201
2007226
2008611
2009904
2010943
20111,364
20121,451
2013411
2014611
2015673
2016941
2017944
2018984
2019841
20201,048
2021906
2022936
2023952
20241,009
20251,310
2026977

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,352 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hallucinationSignal1,47522.321.229,513
confusional stateSignal1,3319.38.89,819
fallSignal1,7916.05.87,616
gait disturbanceSignal7514.44.11,981
somnolenceSignal6923.93.61,468
deathSignal2,3373.02.93,323
pneumoniaSignal7282.52.3674
condition aggravatedSignal6532.42.2541
vomitingSignal9092.22.0580
dizziness8111.81.7305
malaise6731.71.6205
nausea8581.21.133
diarrhoea6591.11.112
fatigue6811.00.90
drug ineffective9570.80.844

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.